Skip to main content

A Study of Baricitinib in Participants With Rheumatoid Arthritis

Completed · Phase 4 · NCT04086745

Conditions: Rheumatoid Arthritis

At a glance

Research payments reported, 2025
$910,722
U.S. investigators named
75
Sites paid
55
Planned or actual enrollment
1,050

About the trial

Sponsor
Eli Lilly and Company (with Incyte Corporation)
Tested
Baricitinib (drug), TNF Inhibitor (drug)
Dates
Started 2020-02-14; completion 2025-05-19
Results posted
Yes

This post-marketing study is designed to compare the safety of baricitinib versus tumor necrosis factor (TNF) inhibitors with respect to venous thromboembolic events (VTEs) when given to participants with rheumatoid arthritis (RA).

From ClinicalTrials.gov, last updated 2026-07-10. Full record, eligibility and contacts (opens in a new tab)

Industry funding

Eli Lilly and Company reported $910,722 in research payments for this study in 2025 (77 payments).

Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.

U.S. investigators named on this study

Clinicians the company named as principal investigators in its Open Payments reports.

Sites paid to run it

  • Arizona Arthritis and Rheumatology Research $357,533
  • Dartmouth Hitchcock Clinic $43,162
  • Dynamed Clinical Research LP, DBA Dm Clinical Research $33,827
  • Western Ky Rheumatology PLLC $30,101
  • Klein and Associates MD PA $28,648
  • Corazon USA LLC $25,604
  • Biopharma Informatic Inc $25,387
  • Prime Clinical Research Inc $24,590
  • Paramount Medical Research and Consulting $24,395
  • Rockford Orthopedic Associates LTD $21,496
  • Arthritis and Rheumatism Assoc LLC $19,681
  • Good Samaritan Regional Medical Center, OR $16,832
  • Danville Orthopedic Clinic Inc $15,153
  • Wcg Clinical Inc $14,608
  • Tpmg Rheumatology $13,455
  • West Broward Rheumatology Associtaes Inc $12,545
  • Biovin Enterprises LLC $11,925
  • "jefferson City Med Grp,pc" $11,793
  • Arthritis and Diabetes Inc $11,750
  • Newport Huntington Medical Group $11,329
  • St Luke's Regional Medical Center, ID $10,590
  • Arthritis Northwest PLLC $10,293
  • "southwest Rheumatology, P.a." $9,766
  • California Research Institute, LLC $9,436
  • Medication Management LLC $8,955
  • Interspond LLC $8,925
  • Facey Medical Foundation $8,924
  • Clinical Investigation Specialists Inc $7,756
  • Iris Rsrch and Development $7,475
  • Rheumatology and Pulmonary Clinic $6,538
  • Advanced Clinical Research Center LLC $6,532
  • Sahni Rheumatology and Therapy PC $6,479
  • Rheumatic Disease Center $6,347
  • Southeastern Rheumatology Alliance DBA Arthritis Center of North Georgia $5,489
  • Rama Research LLC $4,642
  • Gnp Consultants LLC $4,444
  • Altoona Center for Clinical Research PC $4,314
  • Monument Health Rapid City Hospital, SD $3,481
  • Centre for Rheumatology Immunology and Arthritis $3,058
  • Rheumatology Associates of Central $2,793
  • Low Country Rheumatology PA $2,581
  • New York University $2,433
  • Neuwelt Michael C MD Inc $2,402
  • Inland Rheumatology Clinical Trials Inc $2,165
  • Cleveland Clinic, OH $2,001
  • Neccr Prima Care Research LLC $1,995
  • Omni Clinical Research Inc $1,819
  • Sun Valley Arthritis Center LTD $1,374
  • Elligo Health Research Inc $1,187
  • Accurate Clinical Research Inc $756
  • University of Central Florida Research Foundation Inc $527
  • West Tennesse Research Institute $414
  • Felicidad Medical Research LLC $362
  • $288
  • Crowley Core LLC $256
  • Carolina Arthritis Associates $112

Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.